Table 2.
Descriptive statistics regarding the study population.
| Patients population (n = 145) | |
|---|---|
| Age (yy) | 65,97 ± 10,74 |
| Sex (M : F) | 85 : 60 |
| BMI (kg/m2) | 23,94 ± 4,08 |
| ASA score | |
| 1 | 18 (12,4%) |
| 2 | 83 (57,2%) |
| 3 | 41 (28,3%) |
| 4 | 3 (2,1%) |
| Diabetes | 32 (22,1%) |
| Preoperative biliary stenting | 76 (52,4%) |
| Albumin (g/dL) | 4,12 ± 0,37 |
| Cholinesterase (kUI/L) | 8,41 ± 2,31 |
| Total blood protein (g/L) | 68,65 ± 6,15 |
| Hemoglobin (g/dL) | 12,99 ± 1,60 |
| Hematocrit (%) | 38,29 ± 4,56 |
| Neoadjuvant CT-RT | 12 (8,30%) |
| Intraoperative blood loss (mL) | 373,10 ± 265,75 |
| Surgery time (min) | 468,91 ± 68,61 |
| Blood transfusion | 26 (18%) |
| Pylorus preserving PD | 128 (88,2%) |
| LOS (days, median, and range) | 12 (3–108) |
| Overall morbidity | 89 (59,3%) |
| Mortality | 6 (4,1%) |
| Clavien | |
| 0 | 59 (40,70%) |
| I | 6 (4,1%) |
| II | 48 (33,1%) |
| IIIa | 16 (11,0%) |
| IIIb | 7 (4,8%) |
| IV | 3 (2,10%) |
| V | 6 (4,10%) |
| POPF | 41 (28,3%) |
| Grade A | 18 (12,4%) |
| Grade B | 16 (11,0%) |
| Grade C | 7 (4,8%) |
| Biliary fistula | 10 (6,90%) |
| Lymphatic fistula | 9 (6,20%) |
| Postoperative bleeding | 19 (13,10%) |
| Delayed gastric empting | 4 (2,8%) |
| Reintervention | 9 (6,20%) |
| Readmission | 9 (6,20%) |